Circulating microRNA-21 is downregulated in patients with metabolic syndrome

Biomedical and Environmental Sciences

Volumn 29, Issue 5, 2016, Pages 385-389

  He, Qing Fang ^a   Wang, Li Xin ^a   Zhong, Jie Ming ^a   Hu, Ru Ying ^a   Fang, Le ^a   Wang, Hao ^a   Gong, Wei Wei ^a   Zhang, Jie ^a   Pan, Jing ^a   Yu, Min ^a  

^a ZHEJIANG PROVINCIAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MIRN21 MICRORNA, HUMAN;

ADULT; AGED; BLOOD; DOWN REGULATION; FEMALE; GENETICS; HUMAN; MALE; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR;

ADULT; AGED; DOWN-REGULATION; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MICRORNAS; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS;

EID: 84975252032     PISSN: 08953988     EISSN: None     Source Type: Journal    
DOI: 10.3967/bes2016.050     Document Type: Letter

References (10)

1. S Shantikumar, A Caporali, C Emanueli Role of microRNAs in diabetes and its cardiovascular complications Cardiovasc Res 93 2012 583 593
2. DS Karolina, S Tavintharan, A Armugam et al. Circulating miRNA Profiles in Patients with Metabolic Syndrome J Clin Endocrinol Metab 97 2012 E2271 E2276
3. X Chen, Y Ba, L Ma et al. Characterization of microRNAs in serum: a noval class of biomarker for diagnosis of cancer and other diseases Cell Res 18 2008 997 1006
4. S Bátkai, T Thum MicroRNAs in hypertension: mechanisms and therapeutic targets Curr Hypertens Rep 14 2012 79 87
5. Chinese Medical Association Diabetes Society Metabolic Syndrome group The suggestion of the diagnostic criteria of metabolic syndrome by Chinese Medical Association Diabetes Society Chinese Journal of Diabetes Mellitus 12 2004 156 161 (In Chinese)
6. P Keller, V Gburcik, N Petrovic et al. Gene-chip studies of adipogenesis-regulated microRNAs in mouse primary adipocytes and human obesity BMC Endocrine Disorders 11 2011 7
7. F Salas-Pérez, E Codner, E Valencia et al. MicroRNAs miR-21a and miR-93 are down regulated in peripheral blood mononuclear cells (PBMCs) from patients with type 1 diabetes Immunobiology 218 2013 733 737
8. F Fleissner, V Jazbutyte, J Fiedler et al. Asymmetric dimethylarginine impairs angiogenic progenitor cell function in patients with coronary artery through a microRNA-21 dependent mechanism Circ Res 107 2010 138 143
9. C Sun, F Huang, X Liu et al. MiR-21 regulates triglyceride and cholesterol metabolism innon-alcoholic fatty liver disease by targeting HMGCR Int J Mol Med 35 2015 847 853
10. J Hu, Z Wang, BY Liao et al. Human miR-1228 as a stable endogenous control for the quantification of circulating microRNAs in cancer patients Int J Cancer 135 2014 1187 1194